Related Experiment Video
Updated: Jun 19, 2026
07:14
Optogenetic Phase Transition of TDP-43 in Spinal Motor Neurons of Zebrafish Larvae
Published on: February 25, 2022
Coffin-Lowry syndrome.
Patricia Marques Pereira1, Anne Schneider, Solange Pannetier
1Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch, Strasbourg, France.
European Journal of Human Genetics : EJHG
|November 6, 2009
Summary
Coffin-Lowry syndrome (CLS) is a genetic disorder causing intellectual disability and physical abnormalities in males. Mutations in the RPS6KA3 gene disrupt RSK2 protein kinase function, leading to the syndrome’s characteristic symptoms.
Area of Science:
- Genetics
- Molecular Biology
- Clinical Medicine
Background:
- Coffin-Lowry syndrome (CLS) is an X-linked disorder.
- It is characterized by intellectual disability, growth retardation, and skeletal anomalies in males.
- Facial changes and hand abnormalities are diagnostic indicators.
Purpose of the Study:
- To investigate the genetic basis of Coffin-Lowry syndrome.
- To understand the molecular mechanisms underlying RSK2 protein dysfunction.
Main Methods:
- Genetic analysis of the RPS6KA3 gene.
- Assessment of RSK2 protein kinase activity.
- Characterization of mutation heterogeneity.
Main Results:
- CLS is caused by mutations in the RPS6KA3 gene.
- These mutations lead to loss of phosphotransferase activity in the RSK2 kinase.
- Mutations are highly heterogeneous, often resulting in premature translation termination.
Conclusions:
- RPS6KA3 gene mutations are the primary cause of Coffin-Lowry syndrome.
- Loss of RSK2 kinase activity is central to CLS pathogenesis.
- Understanding mutation types aids in diagnosing and potentially treating CLS.
Related Concept Videos
01:20Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
01:19Cushing Syndrome II: Pathophysiology
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
01:26Cushing Syndrome I: Introduction
Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:22Lysosomal Hydrolases
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
01:23Cystic Fibrosis: Pathogenesis
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...